Eric Nuremberger

44PUBLICATIONS
93CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMedical mycologyBasic pharmacologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Oct 25, 2026
Rv2061c, a Putative F 420 -Dependent Oxidoreductase, is Required for Tolerance to Malachite Green and Other Antimicrobials and Oxidative Stress Protection in Mycobacterium tuberculosis.

|Oct 22, 2026
BCG vaccination mitigates tau pathology and restores cognitive function in PS19 mice.

|Oct 01, 2026
One-Dose Efficacy of Long-Acting Sorfequiline in a Mouse Model of Tuberculosis Preventive Therapy.

|Aug 20, 2026
Predicting tuberculosis relapse based on 28-day CFU, RS ratio, and/or drug contribution for novel regimens in the relapsing mouse model.

|Feb 12, 2026
Predicting early bactericidal activity of tuberculosis drug combinations using a translational pharmacokinetic-pharmacodynamic modeling approach.

Niurys de Castro Suarez, Eric L Nuermberger, Jacqueline Ernest

|Oct 22, 2025
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens.

Clara Aguilar-Pérez, Anne J Lenaerts, Cristina Villellas

Pageof 8

Frequent Collaborators

9 joint publications

Radojka M Savic

8 joint publications

Nicole C Ammerman

5 joint publications

Jacqueline P Ernest

4 joint publications

Gregory T Robertson